| Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, ... Journal of clinical oncology 12 (3), 454-466, 1994 | 607 | 1994 |
| p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast M Barbareschi, L Pecciarini, MG Cangi, E Macrì, A Rizzo, G Viale, ... The American journal of surgical pathology 25 (8), 1054-1060, 2001 | 503 | 2001 |
| PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. E Leonardi, S Girlando, G Serio, FA Mauri, G Perrone, S Scampini, ... Journal of clinical pathology 45 (5), 416-419, 1992 | 305 | 1992 |
| BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations M Cigognetti, S Lonardi, S Fisogni, P Balzarini, V Pellegrini, A Tironi, ... Modern Pathology 28 (8), 1043-1057, 2015 | 295 | 2015 |
| High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis M Barbareschi, P Maisonneuve, D Aldovini, MG Cangi, L Pecciarini, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 286 | 2003 |
| Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. G Gasparini, M Barbareschi, C Doglioni, PD Palma, FA Mauri, P Boracchi, ... Clinical cancer research: an official journal of the American Association …, 1995 | 252 | 1995 |
| Two distinct immunopathological profiles in autopsy lungs of COVID-19 R Nienhold, Y Ciani, VH Koelzer, A Tzankov, JD Haslbauer, T Menter, ... Nature communications 11 (1), 5086, 2020 | 250 | 2020 |
| Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas M Barbareschi, F Buttitta, L Felicioni, S Cotrupi, F Barassi, ... Clinical Cancer Research 13 (20), 6064-6069, 2007 | 250 | 2007 |
| CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs M Barbareschi, B Murer, TV Colby, M Chilosi, E Macri, M Loda, C Doglioni The American journal of surgical pathology 27 (2), 141-149, 2003 | 246 | 2003 |
| AKT1E17K in human solid tumours FE Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, ... Oncogene 27 (42), 5648-5650, 2008 | 240 | 2008 |
| Prognostic value of p21 (WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. O Caffo, C Doglioni, S Veronese, M Bonzanini, A Marchetti, F Buttitta, ... Clinical cancer research: an official journal of the American Association …, 1996 | 202 | 1996 |
| p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. A Marchetti, C Doglioni, M Barbareschi, F Buttitta, S Pellegrini, G Bertacca, ... Oncogene 12 (6), 1319-1324, 1996 | 185 | 1996 |
| Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size S Rossi, D Gasparotto, L Toffolatti, C Pastrello, G Gallina, A Marzotto, ... The American journal of surgical pathology 34 (10), 1480-1491, 2010 | 184 | 2010 |
| p53 and c-erb B-2 protein expression in breast carcinomas: An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage … M Barbareschi, E Leonardi, FA Mauri, G Serio, PD Palma American journal of clinical pathology 98 (4), 408-418, 1992 | 178 | 1992 |
| Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: a retrospective study of 103 cases with surgical correlation L Righi, P Graziano, A Fornari, G Rossi, M Barbareschi, A Cavazza, ... Cancer 117 (15), 3416-3423, 2011 | 177 | 2011 |
| Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients M Rugge, A Meggio, C Pravadelli, M Barbareschi, M Fassan, M Gentilini, ... Gut 68 (1), 11-17, 2019 | 167 | 2019 |
| ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach G Pelosi, A Fabbri, F Bianchi, P Maisonneuve, G Rossi, M Barbareschi, ... Journal of Thoracic Oncology 7 (2), 281-290, 2012 | 167 | 2012 |
| Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up M Barbareschi, O Caffo, S Veronese, RD Leek, P Fina, S Fox, ... Human pathology 27 (11), 1149-1155, 1996 | 167 | 1996 |
| The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status C Doglioni, A Dei Tos, L Laurino, C Chiarelli, M Barbareschi, G Viale Virchows Archiv 424, 47-51, 1994 | 167 | 1994 |
| mdm2 gene alterations and mdm2 protein expression in breast carcinomas A Marchetti, F Buttitta, S Girlando, PD Palma, S Pellegrini, P Fina, ... The Journal of pathology 175 (1), 31-38, 1995 | 156 | 1995 |
